Phase 1 SAD/MAD study for AG-181 in healthy subjects and phase 1b design in phenylketonuria

AG-181 - Agios Pharmaceuticals

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jimd.70230

Jerry Vockley 1; Maria Gizewska 2; Matthew Johnston 5; Tammi Schaeffer 4; Chandra Prakash 4; Leonardo Rivadeneyra 4; Krista Sands 4; Tao Song 4; Mike Palte 4; Ms. Elaina Jurecki 5

Aug 17, 2026